Scheduled a pre-IND meeting with the FDA, indicating progress in the regulatory pathway for EL-22. EL-22's novel approach targets muscle preservation for patients undergoing weight loss treatments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results